The All Wales Medicines Strategy Group (AWMSG) has opened a consultation on its Five Year Strategy 2018-2023.
The AWMSG is committed to ensuring that patients in Wales have access to clinically effective and cost-effective medicines that will improve their health outcomes. Over the next five years, the AWMSG will aim to ensure that prescribing in Wales is consistent with the optimal prescribing practices in the rest of the UK. The strategy for the next five years (1 April 2018–31 March 2023) builds on the success of the previous strategy (2013– 2018).
The consultation will run from 15 December 2017 – 19 January 2018
See more consultation on MAP here.